Cite
HARVARD Citation
Yoshii, Y. et al. (2017). Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30‐day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions. Transfusion. 57 (8), pp. 2045-2053. [Online].